This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Enterprise Products (EPD) Q2 Earnings Top Estimates, Fall Y/Y
by Zacks Equity Research
Higher marine terminal volumes of NGL and increased margins from uncontracted storage capacity aid Enterprise Products' (EPD) Q2 earnings.
Enterprise Products (EPD) to Post Q2 Earnings: A Beat in Store?
by Zacks Equity Research
Enterprise Products (EPD) is likely to have generated stable fee-based revenues from its midstream infrastructures, spreading across roughly 50,000 miles, in the June quarter.
Enterprise Products Partners (EPD) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Enterprise Products Partners (EPD) closed at $18.44, marking a -1.02% move from the previous day.
Enterprise Products Partners (EPD) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Enterprise Products Partners (EPD) closed at $18.04, marking a +1.29% move from the previous day.
Enterprise Products Partners (EPD) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Enterprise Products Partners (EPD) closed the most recent trading day at $17.25, moving -1.65% from the previous trading session.
Should Value Investors Buy Enterprise Products Partners (EPD) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights: Novartis, Equinix, Newmont, Enterprise Products Partners and Franco-Nevada
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Novartis, Equinix, Newmont, Enterprise Products Partners and Franco-Nevada
Duke, Dominion End ACP Project: Midstream Operators at Risk? (Revised)
by Zacks Equity Research
To tackle the COVID-19 situation, U.S. pipeline operators are reducing capital expenditures, suspending work or reducing staff at construction sites. The recent Montana ruling is another headwind.
Duke, Dominion End ACP Project: Midstream Operators at Risk?
by Aparajita Dutta
To tackle the COVID-19 situation, U.S. pipeline operators are reducing capital expenditures, suspending work or reducing staff at construction sites. The recent Montana ruling is another headwind.
Top Analyst Reports for Novartis, Equinix & Newmont
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novartis (NVS), Equinix (EQIX) and Newmont (NEM).
Oil and Gas Pipeline MLP's Outlook Promising Despite Coronavirus
by Nilanjan Banerjee
The midstream business model is not significantly exposed to the coronavirus-induced commodity price fluctuations since most infrastructure is being contracted for long term.
Enterprise Products Grabs New Long-Term Propylene Supply Deal
by Zacks Equity Research
Enterprise Products Partners' (EPD) second propane dehydrogenation plant near Mont Belvieu, TX ??? which is currently under construction ??? is likely to come online in second-quarter 2023.
Enterprise Products Partners (EPD) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Enterprise Products Partners (EPD) closed the most recent trading day at $17.91, moving -1.43% from the previous trading session.
Enterprise Products Partners (EPD) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Enterprise Products Partners (EPD) closed at $18.12 in the latest trading session, marking a -0.11% move from the prior day.
Enterprise Products Partners (EPD) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Enterprise Products Partners (EPD) closed at $19.19 in the latest trading session, marking a -1.34% move from the prior day.
The Zacks Analyst Blog Highlights: Merck, CVS Health, Morgan Stanley, Applied Materials and Enterprise Products Partners
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Merck, CVS Health, Morgan Stanley, Applied Materials and Enterprise Products Partners
Enterprise Products Boosts Morgan's Point Ethylene Export
by Zacks Equity Research
Enterprise Products' (EPD) Morgan's Point ethylene terminal is anticipated to have a loading capacity of 2.2 billion pounds per annum by the end of this year.
Top Stock Reports for Merck, CVS & Morgan Stanley
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Merck (MRK), CVS Health (CVS) and Morgan Stanley (MS).
Enterprise Products Partners (EPD) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Enterprise Products Partners (EPD) closed at $19.01 in the latest trading session, marking a -1.14% move from the prior day.
Phillips 66's Bluewater Texas Project FID Many Months Away
by Zacks Equity Research
Phillips 66's (PSX) planned Bluewater Texas oil export terminal is likely to export 2 million barrels of oil a day.
Is Enterprise (EPD) Stock a Solid Choice Right Now?
by Zacks Equity Research
Enterprise (EPD) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Enterprise Products' Oil Terminal Review Temporarily Paused
by Zacks Equity Research
Enterprise Products Partners' (EPD) Sea Port Oil Terminal witnesses temporary suspension of its review process.
Plains All American (PAA) Issues Notes for Debt Refinancing
by Zacks Equity Research
Plains All American Pipeline (PAA) issues notes to refinance the existing debt. This is likely to help the firm lower annual interest expenses.
Enterprise Products Partners (EPD) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Enterprise Products Partners (EPD) closed at $20.40 in the latest trading session, marking a +1.49% move from the prior day.
Enterprise Products (EPD) Up 10.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Enterprise Products (EPD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.